Full Text View
Tabular View
Study Results
Related Studies
Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
This study has been completed.
Study NCT00723073   Information provided by Brigham and Women's Hospital

First Received on July 24, 2008.   Last Updated on August 25, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Febrile Neutropenia
Additional conditions recognized in this trial
Fever
Neutropenia
More general conditions related to this trial
Agranulocytosis
Body Temperature Changes
Hematologic Diseases
Leukocyte Disorders
Leukopenia
Signs and Symptoms
Additional drug interventions recognized in this trial
Antifungal Agents
Caspofungin
Clotrimazole
Micafungin
Miconazole
More general drug interventions related to this trial
14-alpha Demethylase Inhibitors
Anti-Infective Agents
Anti-Infective Agents, Local
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Brigham and Women's Hospital
Astellas Pharma US, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services